CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-08-04 | Shah Pritesh Chief Commercial Officer | Sale | −2,063 | $148.71 | $307K | 74,169 |
| 2021-08-03 | Leonard Frank X Chief Development Officer | Sale | −328 | $149.43 | $49K | 89,158 |
| 2021-08-03 | Shah Pritesh Chief Commercial Officer | Sale | −1,654 | $149.43 | $247K | 76,232 |
| 2021-08-03 | Benaim Ely Chief Medical Officer | Sale | −464 | $150.11 | $70K | 28,144 |
| 2021-08-02 | Leonard Frank X Chief Development Officer | Sale | −713 | $149.38 | $107K | 89,486 |
| 2021-08-02 | DOYLE WILLIAM F Executive Chairman | Sale | −995 | $149.38 | $149K | 554,398 |
| 2021-08-02 | Benaim Ely Chief Medical Officer | Sale | −536 | $149.38 | $80K | 28,608 |
| 2021-07-31 | Shah Pritesh Chief Commercial Officer | Exercise or conversion | +3,717 | $154.01 | $572K | 85,625 |
| 2021-07-31 | Shah Pritesh Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −3,717 | 3,717 | ||
| 2021-07-30 | Benaim Ely Chief Medical Officer | Exercise or conversion | +651 | $83.30 | $54K | 29,795 |
| 2021-07-30 | Benaim Ely Chief Medical Officer | Sale | −651 | $158.96 | $103K | 29,144 |
| 2021-07-30 | Benaim Ely Chief Medical Officer | Exercise or conversion · Options to Buy Ordinary Shares | −651 | 3,253 | ||
| 2021-07-06 | Weinberg Uri Chief Science Officer | Grant or award | +113 | $137.12 | $15K | 31,780 |
| 2021-07-06 | Leonard Frank X Chief Development Officer | Grant or award | +154 | $137.12 | $21K | 90,199 |
| 2021-07-06 | Cordova Ashley Chief Financial Officer | Grant or award | +100 | $137.12 | $14K | 35,993 |
| 2021-07-06 | GROENHUYSEN WILHELMUS CM Chief Operating Officer | Grant or award | +66 | $137.12 | $9K | 150,080 |
| 2021-07-06 | Benaim Ely Chief Medical Officer | Grant or award | +90 | $137.12 | $12K | 29,144 |
| 2021-07-06 | Danziger Asaf Chief Executive Officer | Grant or award | +118 | $137.12 | $16K | 8,302 |
| 2021-07-06 | Shah Pritesh Chief Commercial Officer | Grant or award | +154 | $137.12 | $21K | 77,886 |
| 2021-07-06 | Longsworth Todd Christopher General Counsel | Grant or award | +154 | $137.12 | $21K | 67,868 |
Page 27 of 32 · 638 trades